Tradestie Institutional Equity Comparison Engine

ESPR vs SIGA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ESPR Overall Edge

ESPR Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Esperion Therapeutics, Inc. (ESPR) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while SIGA counters with relative strength in Valuation. Fundamentally, ESPR trades at 10.9x Forward P/E with -8.2% operating margin (+23.2% YoY revenue) versus SIGA at 2.3x Forward P/E and -14.2% operating margin (-49.7% YoY). In options structure, ESPR sits in UNCLASSIFIED (9th %ile IV; Dealer Gamma Walls on Pro) against SIGA sits in BREAKDOWN (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SIGA
ESPR 10.9x vs SIGA 2.3x Fwd P/E
Growth & Margin Winner ESPR
Op Margin -8.2% vs -14.2% ยท YoY +23.2% vs -49.7%
Momentum & Technical Winner ESPR
1Y +158.5% vs -59.4% ยท 52W Pos 68% vs 2%
Options & Structure Winner ESPR
UNCLASSIFIED (9th %ile IV) vs BREAKDOWN (6th %ile IV)
ESPR NASDAQ
Esperion Therapeutics, Inc.
Pharmaceutical Preparations
$3.18
-0.31% 1D
Market Cap $822.0M
1M Return +1.27%
1Y Return +158.54%
Forward P/E 10.9x
Unified AI Score
60.0 / 100 BUY
Tech 55.0 Fund 64.0 Flow 70.0 Mom 70.0
SIGA NASDAQ
SIGA Technologies Inc.
Pharmaceutical Preparations
$2.40
-9.43% 1D
Market Cap $188.3M
1M Return -23.81%
1Y Return -59.39%
Forward P/E 2.3x
Unified AI Score
46.2 / 100 HOLD
Tech 33.0 Fund 53.0 Flow 68.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ESPR +158.54% SIGA -59.39% Spread: +53.24 pp (ESPR Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ESPR Revenue SIGA Revenue ESPR Op. Margin SIGA Op. Margin Margin Edge
FY2018 N/A $480M N/A 74.4% SIGA
FY2019 $150M $30M -62.8% -8.7% SIGA
FY2020 $230M $120M -53.3% 67.6% SIGA
FY2021 $80M $130M -289.0% 66.7% SIGA
FY2022 $80M $110M -237.8% 38.5% SIGA
FY2023 $120M $140M -133.7% 59.8% SIGA
FY2024 $330M $140M 16.4% 50.4% SIGA
FY2025 $400M $90M 15.0% 25.1% SIGA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ESPR (7) vs SIGA (3)
Institutional Metric ESPR SIGA Criterion Row Winner
Market Capitalization Scale $822.0M $188.3M Larger Scale ESPR
Trailing P/E Ratio Valuation 4.6x N/M Lower Multiple ESPR
Forward P/E Ratio Valuation 10.9x 2.3x Lower Multiple SIGA
Revenue Growth (YoY) Growth +23.2% -49.7% Higher Growth ESPR
Operating Margin (TTM) Profitability -8.2% -14.2% Higher Margin ESPR
Net Profit Margin Profitability -1.8% 1.3% Higher Margin SIGA
Return on Equity (ROE) Capital Efficiency -260.8% 0.4% Higher ROE SIGA
52-Week Range Position Momentum 68% ($1โ€“$4) 2% ($2โ€“$7) Stronger Trend ESPR
Beta / 30D Volatility Risk Regime 1.86ฮฒ ยท 6% Vol 0.90ฮฒ ยท 74% Vol Lower Realized Risk ESPR
Unified Institutional Score Composite Signal 60.0 / 100 (BUY) 46.2 / 100 (HOLD) Higher Composite ESPR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ESPR vs SIGA Buy Guide
ESPR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 9th %ile
IV Regime Compressed (<25th %ile)
Live ESPR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SIGA BREAKDOWN
34d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live SIGA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ESPR nor SIGA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.